US Corporate Distress Financial Stress SEC Filings — December 18, 2025

19-12-2025

Krispy Kreme, Inc. filed a Form 8-K on December 19, 2025 (AccNo: 0001857154-25-000143), reporting entry into a material definitive agreement (Item 1.01), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. This appears to be a multi-item mandatory filing filed on the event date.

• ·Specific Items reported: 1.01 (Entry into Material Definitive Agreement), 7.01 (Regulation FD Disclosure), 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; core event is entry into a material definitive agreement, details NOT_DISCLOSED
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED

19-12-2025

Churchill Capital Corp XI filed a multi-item Form 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01), unregistered equity sales (Item 3.02), director/officer changes and compensatory arrangements (Item 5.02), amendments to articles/bylaws (Item 5.03), other events (Item 8.01), and exhibits (Item 9.01). No transaction values, financial metrics, or specific details disclosed. Likely SPAC-related activity but analysis limited to item disclosures.

• ·Multi-item mandatory 8-K filing; items include material agreement, equity sales, governance/officer changes.
• ·Core event: Entry into material definitive agreement (Item 1.01), with supporting disclosures; quantitative data (e.g., transaction value, share count) NOT_DISCLOSED.
• ·Filed same day as event date; compliance with 4-business-day rule presumed.

19-12-2025

MANGOCEUTICALS, INC. filed Form 8-K on 2025-12-19 (AccNo: 0001493152-25-028444) reporting Items 1.01 (Entry into a Material Definitive Agreement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the agreement, events, or financials are disclosed in the summary. Analysis limited to item disclosures; full filing review needed for materiality assessment.

• ·Multi-item 8-K: Items 1.01, 8.01, 9.01
• ·Core event: Entry into Material Definitive Agreement (per Item 1.01)
• ·All quantitative data (transaction value, shares, metrics): NOT_DISCLOSED

19-12-2025

Rocky Mountain Chocolate Factory, Inc. filed a multi-item Form 8-K on December 19, 2025, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), and departures/elections/appointments of directors/officers with compensatory arrangements (Item 5.02), along with exhibits (Item 9.01). No specific transaction details, values, or financial impacts are disclosed in the summary. This filing signals potential strategic and governance changes requiring follow-up for investment decisions.

• ·Multi-item 8-K filing: Items 1.01 (material agreement), 3.02 (unregistered equity sales), 5.02 (officer/director changes), 9.01 (exhibits)
• ·Core events involve a material agreement and equity issuance, with leadership transitions; all quantitative data (transaction value, share count, etc.) NOT_DISCLOSED
• ·Compliance with 8-K timing appears met (filed same day as event), but voluntary/mandatory status and details NOT_DISCLOSED

19-12-2025

Northern Technologies International Corp filed an 8-K on 2025-12-19 disclosing entry into a Material Definitive Agreement under Item 1.01 with exhibits under Item 9.01. No details on the agreement, transaction value, or financial impacts are provided. Analysis limited to filing summary.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; mandatory disclosure for Item 1.01
• ·Core event: Material Definitive Agreement; all quantitative data (value, shares, metrics) NOT_DISCLOSED

19-12-2025

BeOne Medicines Ltd. filed an 8-K on December 19, 2025, reporting under Item 1.02 the termination of a material definitive agreement. No details on the agreement's nature, value, or financial impacts are disclosed. This event is inherently negative but lacks quantification for precise assessment.

• ·Item 1.02: Termination of a Material Definitive Agreement
• ·No transaction value, share count, or financial metrics disclosed
• ·Single-item 8-K filing; sector not specified

19-12-2025

Cannabist Co Holdings Inc. filed a Form 8-K on 2025-12-19 reporting entry into (Item 1.01) and termination of (Item 1.02) material definitive agreements, Regulation FD disclosure (Item 7.01), and exhibits (Item 9.01). No specific details on agreements, parties, values, or impacts are disclosed in the provided summary. This multi-item filing signals potentially offsetting strategic changes but lacks quantification.

• ·Multi-item filing: Items 1.01, 1.02, 7.01, 9.01 – mandatory for material events.
• ·Core event: Entry and termination of material agreements; all transaction details NOT_DISCLOSED.
• ·Timing compliance and financial impacts NOT_DISCLOSED.

19-12-2025

COTY INC. filed a Form 8-K on 2025-12-19 reporting Items 1.01 (Entry into Material Definitive Agreement), 2.06 (Material Impairments), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction value, financial impacts, or quantitative metrics are disclosed in the provided summary. This multi-item filing signals potentially significant developments, primarily negative due to material impairments.

• ·Multi-item 8-K filing: Items 1.01, 2.06, 8.01, 9.01
• ·Core events: Material agreement and impairments (exact nature NOT_DISCLOSED)
• ·All quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED

19-12-2025

ArrowMark Financial Corp. filed a Form 8-K on December 19, 2025 (AccNo: 0001104659-25-122683), reporting Items 1.01 (Entry into a Material Definitive Agreement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, events, or financials disclosed in the provided summary. All transaction values, impacts, and quantitative data are NOT_DISCLOSED.

• ·Multi-item 8-K: Items 1.01, 8.01, 9.01
• ·Item 1.01 signals entry into Material Definitive Agreement (core event unspecified)
• ·No numerical data (e.g., transaction value, share count) or financial impacts extracted

19-12-2025

abrdn Income Credit Strategies Fund filed a multi-item 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation/bylaws or fiscal year change (Item 5.03), and exhibits (Item 9.01). No specific transaction values, share counts, or financial metrics are disclosed in the provided summary. Analysis limited to item triggers; full filing review required for details.

• ·Multi-item mandatory 8-K filing with Items 1.01, 3.02, 5.03, 9.01
• ·Core events: material agreement, unregistered equity sales, governance/fiscal changes
• ·All quantitative data (transaction value, shares, percentages) NOT_DISCLOSED

19-12-2025

BrightSpire Capital, Inc. filed Form 8-K on 2025-12-19 disclosing entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits (Item 9.01). No specific transaction details, values, or impacts are stated in the provided summary. This is a multi-item mandatory filing compliant with SEC 8-K requirements.

• ·Multi-item filing: Items 1.01, 2.03, 9.01 reported
• ·Core event: Entry into material definitive agreement and new financial obligation
• ·All quantitative data (transaction value, shares, metrics): NOT_DISCLOSED

19-12-2025

ECD Automotive Design, Inc. filed a multi-item Form 8-K on December 19, 2025 (AccNo: 0001437749-25-038336), reporting Items 3.03 (Material Modifications to Rights of Security Holders), 5.02 (Departure of Directors/Officers; Compensatory Arrangements), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific event details, transaction values, financial metrics, or quantitative data provided in summary. Analysis limited; full filing required for deeper insights.

• ·Multi-item 8-K filing: Items 3.03, 5.02, 7.01, 9.01
• ·Potential governance changes (rights modifications, director/officer shifts)
• ·Timely filing on event date; voluntary/mandatory mix per items

19-12-2025

USBC, Inc. filed an 8-K on December 19, 2025 (AccNo: 0001161697-25-000473), reporting entry into a Material Definitive Agreement under Item 1.01 and attaching exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Analysis is limited to filing structure; core event details are NOT_DISCLOSED.

• ·8-K reports Items 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event: Entry into a Material Definitive Agreement (details NOT_DISCLOSED).
• ·Quantitative data (transaction value, share count, financial metrics): all NOT_DISCLOSED.

19-12-2025

Abacus Global Management, Inc. filed a Form 8-K on December 19, 2025, reporting under Item 3.01 a notice of delisting or failure to satisfy continued listing rules, alongside Item 7.01 Regulation FD disclosure and Item 9.01 exhibits. This indicates a material adverse event involving delisting from US markets. No specific reasons, financial impacts, or quantitative details are disclosed in the provided filing summary.

• ·Multi-item 8-K filing: Items 3.01 (delisting notice), 7.01 (Reg FD), 9.01 (exhibits)
• ·Core event: Notice of delisting or listing rule failure; timing aligns with filing date
• ·All transaction values, share counts, financial metrics: NOT_DISCLOSED

19-12-2025

Galectin Therapeutics Inc. filed an 8-K on December 19, 2025, reporting entry into a Material Definitive Agreement under Item 1.01, with exhibits under Item 9.01. No details on the agreement terms, transaction value, or financial impacts are disclosed in the provided summary. Analysis limited to filing structure; critical details NOT_DISCLOSED.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event: Entry into undisclosed Material Definitive Agreement.
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED.

19-12-2025

Bark, Inc. filed an 8-K on December 19, 2025 (AccNo: 0001628280-25-058100), reporting Item 3.01 Notice of Delisting or Failure to Satisfy Continued Listing Rule and Item 8.01 Other Events. This signals a delisting from US markets due to non-compliance with listing standards. No specific details on reasons, financial impacts, or transaction values are disclosed.

• ·8-K items: 3.01 (delisting notice) and 8.01 (other events); multi-item filing.
• ·Core event: Notice of delisting or listing rule failure; voluntary/mandatory not specified.
• ·All quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED.

19-12-2025

Boxlight Corp filed a multi-item Form 8-K on December 19, 2025, disclosing Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of modifications, amendments, or disclosures are provided in the summary, limiting analysis depth. All quantitative data such as transaction values, share counts, or financial metrics are NOT_DISCLOSED.

• ·Multi-item 8-K filing covering security holder rights changes, governance amendments, and Reg FD info
• ·Mandatory disclosure under SEC rules for material events; filing timeliness not assessable without event date
• ·Core event involves governance changes; strategic/financial impacts NOT_DISCLOSED

19-12-2025

Mirum Pharmaceuticals, Inc. filed a Form 8-K on December 19, 2025, reporting Items 1.01 (Entry into Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses a material event but lacks specific details on transaction terms or financial impacts. All quantitative data such as transaction value, share count, or percentage changes are NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01, 3.02, 7.01, 9.01.
• ·Core events: Material definitive agreement and unregistered equity sales.
• ·No numerical values or detailed impacts explicitly stated.

19-12-2025

BioMarin Pharmaceutical Inc. filed an 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Analysis is limited to reported items; full filing review required for deeper insights.

• ·Multi-item 8-K filing: Items 1.01, 7.01, 9.01
• ·Core event: Entry into material definitive agreement (NOT_DISCLOSED details)
• ·All quantitative data (transaction value, shares, metrics): NOT_DISCLOSED

19-12-2025

XCel Brands, Inc. filed an 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01) and unregistered sales of equity securities (Item 3.02), with exhibits attached (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. This is a multi-item mandatory filing with limited visibility into implications.

• ·Multi-item 8-K filing: Items 1.01 (Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), and 9.01 (Financial Statements and Exhibits).
• ·Core events involve a material agreement and equity sales, but transaction details, values, and impacts NOT_DISCLOSED.
• ·Filed same day as event; compliance with 4-business-hour rule NOT_DISCLOSED.

19-12-2025

Trio-Tech International filed a Form 8-K on December 19, 2025 (AccNo: 0001437749-25-038362), reporting under Items 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific details on the nature of modifications, amendments, or disclosures are provided in the summary. All quantitative data such as transaction values, share counts, or financial metrics are NOT_DISCLOSED.

• ·Multi-item 8-K filing covering shareholder rights changes, governance amendments, Reg FD info, and exhibits.
• ·Filed same day as event date (2025-12-19), likely within 4-business-day requirement.
• ·Core event details, dollar values, and financial impacts NOT_DISCLOSED; analysis limited to item disclosures.

19-12-2025

Amicus Therapeutics, Inc. filed a Form 8-K on December 19, 2025, disclosing Item 1.01 (Entry into Material Definitive Agreement), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the core event, transaction value, or financial impacts provided in the summary. Analysis is constrained by lack of filing content; all quantitative data is NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01, 5.03, 7.01, 9.01 reported.
• ·Mandatory disclosure likely due to material agreement and governance changes.
• ·No quantitative data (e.g., transaction value, share count: NOT_DISCLOSED); critical details missing.

19-12-2025

Actelis Networks Inc filed a Form 8-K on December 19, 2025, disclosing entry into a material definitive agreement under Item 1.01 and attaching financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are provided in the summary. Analysis is limited to filing metadata, with all quantitative data NOT_DISCLOSED.

• ·8-K reports Items 1.01 (Material Definitive Agreement) and 9.01 (Exhibits).
• ·Multi-item filing; core event is entry into undisclosed material agreement.
• ·No numerical data (e.g., transaction value, shares: NOT_DISCLOSED); requires full filing review.

19-12-2025

The company filed an 8-K on December 19, 2025 (AccNo: 0001193125-25-326002), reporting under Items 1.01 (Entry into a Material Definitive Agreement) and 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement). No specific details on the agreement, transaction value, or financial terms are disclosed in the provided filing excerpt. Analysis is limited to the reported items, with all quantitative data NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01 and 2.03.
• ·Event date aligns with filing date (December 19, 2025); compliance with 4-business-day requirement cannot be confirmed without full filing.
• ·Core event involves a material agreement and new financial obligation; no dollar values, strategic details, or impacts disclosed.

19-12-2025

Marvion Inc. filed a Form 8-K on December 19, 2025 (AccNo: 0001683168-25-009274), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, parties, terms, or financial impacts are disclosed in the provided summary. All quantitative data such as transaction value, share count, or financial metrics are NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01 (Material Definitive Agreement) and 9.01 (Exhibits)
• ·Mandatory disclosure of material event; filed same day as event date
• ·No sector, transaction details, or numerical values provided; full filing review required

19-12-2025

AmBase Corp filed an 8-K on December 19, 2025 (AccNo: 0001140361-25-046179), reporting under Item 1.01 entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Full filing review required for accurate assessment.

• ·Items 1.01 and 9.01 reported; multi-item filing
• ·Core event: Entry into Material Definitive Agreement (details NOT_DISCLOSED)
• ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED

19-12-2025

Profound Medical Corp. filed an 8-K on December 19, 2025, disclosing entry into a material definitive agreement (Item 1.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are provided in the available summary. Analysis is limited to filing metadata, with all quantitative data NOT_DISCLOSED.

• ·Multi-item 8-K filing (Items 1.01, 8.01, 9.01); Item 1.01 indicates mandatory disclosure of a material definitive agreement.
• ·Core event: Entry into material definitive agreement (details NOT_DISCLOSED); timing of filing vs. event and business day compliance NOT_DISCLOSED.
• ·No revenue, balance sheet, or guidance impacts mentioned; quantitative extraction: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

19-12-2025

Sarepta Therapeutics filed an 8-K on December 19, 2025, reporting under Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), with exhibits under Item 9.01. No specific details on the agreement, transaction value, or terms are disclosed in the provided summary. This multi-item filing signals a potentially significant corporate event, but analysis is limited without full filing content.

• ·Multi-item 8-K filing: Items 1.01, 2.03, and 9.01.
• ·Core event involves material definitive agreement and new financial obligation.
• ·All quantitative data (transaction value, share count, etc.) NOT_DISCLOSED.

19-12-2025

Tigo Energy, Inc. filed an 8-K on December 19, 2025 (AccNo: 0001213900-25-123890), reporting entry into a Material Definitive Agreement under Item 1.01 and including Financial Statements and Exhibits under Item 9.01. No details on the agreement's terms, value, parties, or impact are disclosed in the provided summary. Analysis is limited; full filing review required for materiality assessment.

• ·Multi-item 8-K: Items 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits)
• ·Core event: Entry into undisclosed Material Definitive Agreement; all quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED
• ·Timing, compliance, strategic importance, financial impacts, and market reactions NOT_DISCLOSED

19-12-2025

ONE Gas, Inc. filed a Form 8-K on December 19, 2025, disclosing entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial terms are provided in the summary. This is a multi-item mandatory filing signaling a significant corporate commitment.

• ·Reported Items: 1.01 (Material Definitive Agreement), 2.03 (Financial Obligation), 9.01 (Exhibits)
• ·Core event: Entry into undisclosed material agreement creating financial obligation
• ·All quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED

19-12-2025

Yelp Inc. filed an 8-K on December 19, 2025, reporting under Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement). No specific details on the agreement, transaction value, or financial terms are disclosed in the provided summary. Analysis is limited to item disclosures; all quantitative data is NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01 and 2.03.
• ·Core event involves a material definitive agreement creating a financial obligation.
• ·No dollar values, share counts, or financial metrics disclosed.

19-12-2025

LQR House Inc. filed an 8-K on December 19, 2025 (AccNo: 0001213900-25-123834), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, events, transaction values, or financial impacts are disclosed in the provided summary. Analysis is limited to filing structure; all quantitative data is NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01, 8.01, and 9.01.
• ·Item 1.01 indicates entry into a material definitive agreement (mandatory disclosure).
• ·Timing compliance and core event details NOT_DISCLOSED.

19-12-2025

Lakeside Holding Ltd filed a multi-item Form 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), and officer/director changes including compensatory arrangements (Item 5.02). No specific transaction details, values, or financial metrics are disclosed in the provided summary. Full filing review required for precise impacts.

• ·Multi-item mandatory 8-K filing: Items 1.01, 3.02, 5.02, 9.01
• ·Core events involve material agreement, equity sales, and leadership changes; all quantitative data NOT_DISCLOSED
• ·Timing compliant with 4-business-day window based on filing date matching event date

19-12-2025

PAR PACIFIC HOLDINGS, INC. filed a Form 8-K on 2025-12-19 reporting Items 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), and 9.01 (Financial Statements and Exhibits). No specific details on the agreement, transaction value, or financial terms are disclosed in the provided summary. Core event involves a material agreement with financial obligations, but all quantitative data is NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01, 2.03, 9.01.
• ·Mandatory disclosure for material events; filed same day as event date.
• ·No quantitative data (transaction value, share count, financial metrics: all NOT_DISCLOSED).

19-12-2025

Martin Marietta Materials Inc filed a Form 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation (Item 2.03), with exhibits (Item 9.01). No specific transaction details, dollar values, or quantitative impacts are disclosed in the provided summary. Analysis is limited to filing items; critical details NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01, 2.03, and 9.01.
• ·Core event involves material agreement and new financial obligation.
• ·No numerical data (transaction value, shares, metrics) disclosed.

19-12-2025

Keurig Dr Pepper Inc. filed an 8-K on 2025-12-19 reporting entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation (Item 2.03), with exhibits under Item 9.01. No specific transaction details, dollar values, or terms are disclosed in the provided summary. This indicates a potentially significant financing or contractual event requiring further review of exhibits.

• ·Multi-item 8-K filing: Items 1.01, 2.03, and 9.01
• ·Core event: Material definitive agreement creating financial obligation; all quantitative data NOT_DISCLOSED
• ·Compliance with 8-K requirements presumed; timing and details NOT_DISCLOSED

19-12-2025

Ouster, Inc. filed an 8-K on 2025-12-19 reporting entry into a Material Definitive Agreement under Item 1.01, with exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Analysis is limited to filing structure; full filing review required for deeper insights.

• ·Multi-item 8-K filing: Items 1.01 (Material Definitive Agreement) and 9.01 (Exhibits)
• ·Core event: Entry into undisclosed Material Definitive Agreement
• ·All quantitative data (transaction value, shares, financial metrics): NOT_DISCLOSED

19-12-2025

Cue Biopharma, Inc. filed an 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Analysis is limited to filing structure; core event details are NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01, 8.01, and 9.01.
• ·Item 1.01 signals entry into a material definitive agreement, inherently material per SEC rules.
• ·No quantitative data (transaction value, shares, financial metrics) or strategic details disclosed.

19-12-2025

TXNM Energy Inc filed a multi-item 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation (Item 2.03), and Regulation FD disclosure (Item 7.01). No details on the core event, transaction value, terms, or financial metrics are disclosed in the provided summary. Analysis is limited, indicating a potentially significant financing or agreement event requiring review of full filing.

• ·Multi-item mandatory 8-K: Items 1.01, 2.03, 7.01, 9.01 reported.
• ·Core event involves material agreement and financial obligation; all quantitative data NOT_DISCLOSED.
• ·Timing compliance and strategic details unknown from summary.

19-12-2025

INSIGHT ENTERPRISES INC filed an 8-K on 2025-12-19 reporting Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and 9.01 (Financial Statements and Exhibits). No specific transaction details, dollar values, or financial metrics are disclosed in the provided summary. This is a multi-item mandatory filing indicating a material event.

• ·Multi-item 8-K: Items 1.01, 2.03, 9.01
• ·Core event: Entry into material definitive agreement creating financial obligation
• ·All quantitative data (transaction value, share count, etc.): NOT_DISCLOSED

19-12-2025

Compass Diversified Holdings filed an 8-K on 2025-12-19 disclosing entry into a Material Definitive Agreement (Item 1.01), Regulation FD Disclosure (Item 7.01), and Financial Statements/Exhibits (Item 9.01). No specific transaction details, financial metrics, or impacts are disclosed in the provided summary. Analysis limited to filing items due to lack of content.

• ·Multi-item 8-K: Items 1.01, 7.01, 9.01
• ·Core event: Entry into Material Definitive Agreement (details NOT_DISCLOSED)
• ·Filed via AccNo: 0001345126-25-000089; timing compliance NOT_DISCLOSED

19-12-2025

New Fortress Energy Inc. filed an 8-K on December 19, 2025, reporting entry into a material definitive agreement under Item 1.01 and including financial statements/exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. This constitutes a mandatory disclosure of a material event.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Filed same day as event (2025-12-19); timing within 4 business hours NOT_DISCLOSED.
• ·Core event: Entry into material definitive agreement; all quantitative data (value, shares, metrics) NOT_DISCLOSED.

19-12-2025

Inmune Bio, Inc. filed an 8-K on December 19, 2025, disclosing entry into a Material Definitive Agreement under Item 1.01, with exhibits under Item 9.01. No details on the agreement's nature, value, or terms are provided in the filing summary. Analysis limited to explicitly stated items; all other data NOT_DISCLOSED.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; core event is entry into unnamed material agreement
• ·Transaction value, share count, financial metrics: NOT_DISCLOSED

19-12-2025

Hyperscale Data, Inc. filed a Form 8-K on December 19, 2025, reporting entry into a Material Definitive Agreement (Item 1.01), Regulation FD Disclosure (Item 7.01), and Financial Statements and Exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Analysis is limited to filing structure, indicating a potentially significant but undisclosed event.

• ·Multi-item 8-K filing: Items 1.01, 7.01, 9.01
• ·Core event: Entry into Material Definitive Agreement (Item 1.01)
• ·Filed December 19, 2025; AccNo: 0001214659-25-018293; sector NOT_DISCLOSED

19-12-2025

UWM Holdings Corp filed a Form 8-K on December 19, 2025 (AccNo: 0001783398-25-000065), reporting entry into a material definitive agreement under Item 1.01, with financial statements and exhibits under Item 9.01. No details on the agreement's nature, terms, value, or impact are explicitly stated in the provided summary. This is a multi-item mandatory disclosure of a material event.

• ·Items reported: 1.01 (Entry into a Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits)
• ·Core event: Entry into unspecified material definitive agreement
• ·All quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED

19-12-2025

ProFrac Holding Corp. filed an 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation (Item 2.03), with exhibits attached (Item 9.01). No specific details on the agreement, transaction value, or financial terms are disclosed in the provided summary. This multi-item filing indicates a potentially significant development requiring review of the full document.

• ·Reported Items: 1.01 (Material Definitive Agreement), 2.03 (Financial Obligation), 9.01 (Exhibits)
• ·Multi-item mandatory 8-K filing on event date (December 19, 2025)
• ·Core event involves a material agreement creating financial obligations; all quantitative details NOT_DISCLOSED

19-12-2025

Ares Commercial Real Estate Corp filed an 8-K on December 19, 2025, reporting Items 1.01 (Entry into a Material Definitive Agreement) and 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement). No specific transaction details, dollar values, or terms are disclosed in the provided summary. This appears to be a mandatory multi-item filing with limited visibility into financial impact.

• ·Multi-item 8-K filing covering Items 1.01 and 2.03.
• ·Core event involves a material agreement and new financial obligation; all quantitative data (e.g., transaction value, share count) NOT_DISCLOSED.
• ·No guidance on timing compliance, market reaction, or related filings provided.

19-12-2025

Vine Hill Capital Investment Corp. II filed a Form 8-K on December 19, 2025, reporting multiple events under Items 1.01 (Entry into Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure/Election of Directors/Officers), 5.03 (Amendments to Articles/Bylaws), 8.01 (Other Events), and 9.01 (Exhibits). This is a multi-item mandatory filing with no quantitative details such as transaction values, share counts, or financial metrics disclosed. Analysis limited by absence of filing content beyond item list.

• ·Multi-item 8-K: Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01 reported
• ·Core events involve material agreements, equity sales, governance changes; all other specifics NOT_DISCLOSED
• ·Filing timing, financial impacts, and market reactions NOT_DISCLOSED

19-12-2025

Wheels Up Experience Inc. filed an 8-K on December 19, 2025, reporting a Notice of Delisting or Failure to Satisfy Continued Listing Rule (Item 3.01), Regulation FD Disclosure (Item 7.01), and Financial Statements/Exhibits (Item 9.01). This indicates a delisting event from the US market, but specific reasons, timelines, or financial impacts are NOT_DISCLOSED. Multi-item mandatory filing with high materiality due to delisting notice.

• ·Specific Items: 3.01 (Delisting Notice), 7.01 (Reg FD), 9.01 (Exhibits) - multi-item filing.
• ·Core event: Notice of delisting or listing rule failure; all quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED.
• ·Compliance: Appears mandatory; timing within same day but 4-hour filing verification NOT_DISCLOSED.

19-12-2025

IO Biotech, Inc. filed an 8-K on December 19, 2025, reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No specific reasons, financial details, or transaction values are disclosed in the provided filing summary. This indicates a material negative event for US-listed shares.

• ·Item 3.01 reported: Notice of delisting or failure to satisfy listing standards
• ·Single-item 8-K filing (Item 3.01 only)
• ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED

19-12-2025

Playboy, Inc. filed an 8-K on December 19, 2025 (AccNo: 0001628280-25-058362) disclosing under Item 3.01 a notice of delisting or failure to satisfy continued listing rules, and under Item 5.02 changes in directors or officers. No specific details on delisting reasons, transaction values, or officer identities are provided in the summary. This indicates potential liquidity and leadership risks for US equity investors.

• ·Multi-item 8-K filing reporting Items 3.01 (delisting notice) and 5.02 (director/officer changes).
• ·Core event: Notice of delisting or listing rule failure; officer departures/appointments.
• ·No quantitative data (e.g., transaction values, share counts) disclosed.

19-12-2025

Streamex Corp. filed a Form 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific transaction details, values, or impacts are disclosed in the provided summary. This is a multi-item mandatory filing with limited visibility into core events.

• ·Multi-item 8-K filing covering Items 1.01, 2.03, 3.02, 8.01, and 9.01; filing date aligns with event but intra-day timing NOT_DISCLOSED.
• ·Core events involve material agreement, new financial obligation, and unregistered equity sales; all quantitative data (value, shares, etc.) NOT_DISCLOSED.
• ·Compliance with 8-K requirements presumed; no forward-looking statements or risk factors detailed in summary.

19-12-2025

Tectonic Financial, Inc. filed a Form 8-K on December 19, 2025, reporting Items 1.01 (Entry into Material Definitive Agreement), 5.02 (Departure/Election of Directors/Officers/Compensatory Arrangements), 8.01 (Other Events), and 9.01 (Financial Statements/Exhibits). This is a multi-item mandatory disclosure with no specific transaction details, personnel names, or quantitative data provided in the summary. Analysis limited to item descriptions; all financial metrics and impacts NOT_DISCLOSED.

• ·Multi-item 8-K: Items 1.01, 5.02, 8.01, 9.01 reported
• ·Core events include material agreement and leadership changes (FACTS from items)
• ·No transaction value, share counts, percentages, or financial metrics disclosed (NOT_DISCLOSED)

19-12-2025

Luminar Technologies, Inc. filed an 8-K on December 19, 2025, reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No additional details on reasons, timelines, or financial impacts are disclosed. This signals potential removal from major US exchanges, increasing illiquidity risks.

• ·Single-item 8-K filing under Item 3.01 only
• ·Event: Notice of delisting or listing rule failure; all quantitative data (transaction value, shares, percentages, financial metrics) NOT_DISCLOSED
• ·Sector not specified; no timing, compliance, or related filings details provided

19-12-2025

Firefly Neuroscience, Inc. filed an 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01) and unregistered sales of equity securities (Item 3.02), with exhibits attached (Item 9.01). No specific details on the agreement, transaction value, share count, or financial impacts are disclosed in the provided summary. Analysis is limited due to lack of filing content.

• ·Multi-item 8-K filing: Items 1.01 (Material Definitive Agreement), 3.02 (Unregistered Equity Sales), 9.01 (Exhibits)
• ·Core events involve a material agreement and equity sales; all quantitative data (transaction value, share count, etc.) NOT_DISCLOSED
• ·Compliance with 8-K filing assumed; no timing of event or voluntary/mandatory details specified

19-12-2025

PSQ Holdings, Inc. filed an 8-K on December 19, 2025 (AccNo: 0001104659-25-123291), reporting entry into a material definitive agreement (Item 1.01), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Analysis limited to filing metadata; full content required for deeper insights.

• ·Multi-item 8-K filing: Items 1.01 (Material Definitive Agreement), 7.01 (Reg FD Disclosure), 9.01 (Exhibits).
• ·Core event: Entry into material agreement (details NOT_DISCLOSED).
• ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED.

19-12-2025

ScanSource, Inc. filed a Form 8-K on December 19, 2025, reporting entry into a material definitive agreement (Item 1.01), termination of another (Item 1.02), and creation of a direct financial obligation (Item 2.03), with exhibits (Item 9.01). No specific details, values, or transaction terms are disclosed in the provided summary. This multi-item filing indicates mixed events requiring review of attached exhibits for impact assessment.

• ·Multi-item 8-K filing: Items 1.01, 1.02, 2.03, and 9.01 reported.
• ·Core events involve new agreement entry, prior agreement termination, and new financial obligation; all details NOT_DISCLOSED.
• ·Filed same day as event date; compliance with 4-business-day window presumed but timing details NOT_DISCLOSED.

19-12-2025

IN8BIO, INC. filed a Form 8-K on December 19, 2025 (AccNo: 0001193125-25-327097), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, or quantitative data disclosed in the summary. Core events involve a material agreement and equity sales, but impacts are NOT_DISCLOSED.

• ·Multi-item 8-K: Items 1.01, 3.02, 9.01 reported
• ·Core events: Material definitive agreement and unregistered equity sales (details NOT_DISCLOSED)
• ·No quantitative data: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED